1 Ocak 2022 Dergi makalesi Açık Erişim

Erdogan, Ebru; Yalcin, Koray; Hemsinlioglu, Cansu; Sezgin, Aslihan; Seyis, Utku; Kancagi, Derya Dilek; Tastan, Cihan; Yurtsever, Bulut; Turan, Raife Dilek; Cakirsoy, Didem; Abanuz, Selen; Karakus, Gozde Sir; Elek, Muhammer; Bekoz, Huseyin Saffet; Gemici, Ali Ihsan; Sargin, Deniz; Arat, Mutlu; Ferhanoglu, Burhan; Pekguc, Ebru; Ornek, Serdar; Ornek, Serdar

DataCite XML

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/259959</identifier>
  <creators>
    <creator>
      <creatorName>Erdogan, Ebru</creatorName>
      <givenName>Ebru</givenName>
      <familyName>Erdogan</familyName>
      <affiliation>Acibadem Altunizade Hosp, Hematol Unit, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Yalcin, Koray</creatorName>
      <givenName>Koray</givenName>
      <familyName>Yalcin</familyName>
    </creator>
    <creator>
      <creatorName>Hemsinlioglu, Cansu</creatorName>
      <givenName>Cansu</givenName>
      <familyName>Hemsinlioglu</familyName>
      <affiliation>Acibadem Labcell Cellular Therapy Ctr, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Sezgin, Aslihan</creatorName>
      <givenName>Aslihan</givenName>
      <familyName>Sezgin</familyName>
      <affiliation>Acibadem Altunizade Hosp, Hematol Unit, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Seyis, Utku</creatorName>
      <givenName>Utku</givenName>
      <familyName>Seyis</familyName>
      <affiliation>Acibadem Labcell Cellular Therapy Ctr, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Kancagi, Derya Dilek</creatorName>
      <givenName>Derya Dilek</givenName>
      <familyName>Kancagi</familyName>
      <affiliation>Acibadem Labcell Cellular Therapy Ctr, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Tastan, Cihan</creatorName>
      <givenName>Cihan</givenName>
      <familyName>Tastan</familyName>
    </creator>
    <creator>
      <creatorName>Yurtsever, Bulut</creatorName>
      <givenName>Bulut</givenName>
      <familyName>Yurtsever</familyName>
      <affiliation>Acibadem Labcell Cellular Therapy Ctr, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Turan, Raife Dilek</creatorName>
      <givenName>Raife Dilek</givenName>
      <familyName>Turan</familyName>
      <affiliation>Acibadem Labcell Cellular Therapy Ctr, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Cakirsoy, Didem</creatorName>
      <givenName>Didem</givenName>
      <familyName>Cakirsoy</familyName>
      <affiliation>Acibadem Labcell Cellular Therapy Ctr, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Abanuz, Selen</creatorName>
      <givenName>Selen</givenName>
      <familyName>Abanuz</familyName>
      <affiliation>Acibadem Labcell Cellular Therapy Ctr, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Karakus, Gozde Sir</creatorName>
      <givenName>Gozde Sir</givenName>
      <familyName>Karakus</familyName>
      <affiliation>Acibadem Labcell Cellular Therapy Ctr, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Elek, Muhammer</creatorName>
      <givenName>Muhammer</givenName>
      <familyName>Elek</familyName>
      <affiliation>Acibadem Labcell Cellular Therapy Ctr, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Bekoz, Huseyin Saffet</creatorName>
      <givenName>Huseyin Saffet</givenName>
      <familyName>Bekoz</familyName>
      <affiliation>Medipol Univ, Hematol Unit, Fac Med, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Gemici, Ali Ihsan</creatorName>
      <givenName>Ali Ihsan</givenName>
      <familyName>Gemici</familyName>
      <affiliation>Medipol Univ, Hematol Unit, Fac Med, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Sargin, Deniz</creatorName>
      <givenName>Deniz</givenName>
      <familyName>Sargin</familyName>
    </creator>
    <creator>
      <creatorName>Arat, Mutlu</creatorName>
      <givenName>Mutlu</givenName>
      <familyName>Arat</familyName>
      <affiliation>Istanbul Florence Nightingale Hosp, Hematol Unit, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Ferhanoglu, Burhan</creatorName>
      <givenName>Burhan</givenName>
      <familyName>Ferhanoglu</familyName>
      <affiliation>VKV Amer Hosp, Hematol Unit, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Pekguc, Ebru</creatorName>
      <givenName>Ebru</givenName>
      <familyName>Pekguc</familyName>
      <affiliation>VKV Amer Hosp, Hematol Unit, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Ornek, Serdar</creatorName>
      <givenName>Serdar</givenName>
      <familyName>Ornek</familyName>
      <affiliation>VKV Amer Hosp, Hematol Unit, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Ornek, Serdar</creatorName>
      <givenName>Serdar</givenName>
      <familyName>Ornek</familyName>
      <affiliation>VKV Amer Hosp, Hematol Unit, Istanbul, Turkey</affiliation>
    </creator>
  </creators>
  <titles>
    <title>Preliminary Report Of The Academic Car-T (Isikok-19) Cell Clinical Trial In Turkey: Characterization Of Product And Outcomes Of Clinical Application</title>
  </titles>
  <publisher>Aperta</publisher>
  <publicationYear>2022</publicationYear>
  <dates>
    <date dateType="Issued">2022-01-01</date>
  </dates>
  <resourceType resourceTypeGeneral="Text">Journal article</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/259959</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.4274/tjh.galenos.2022.2022.0193</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">Objective: Chimeric antigen receptor T (CAR-T) cell therapies have already made an impact on the treatment of B-cell malignancies. Although CAR-T cell therapies are promising, there are concerns about commercial products regarding their affordability and sustainability. In this preliminary study, the results of the first production and clinical data of an academic CAR-T cell (ISIKOK-19) trial in Turkey are presented.</description>
  </descriptions>
</resource>